IFN-γ is a key effector cytokines for anti-tumorigenic NK, CD8 and CD4 T cells affecting cancer cells and multiple immune cells [207] and its proper induction and signaling is essential for the success of immunotherapies in many cancers and is required for suppression of BC [208]. This evidence concerns the gene CD4 and breast cancer.